US military leaders warn of rising threat from drug-resistant bacteria on battlefields

US military leaders are raising alarms about a growing threat on battlefields: drug-resistant bacteria. Recent data from combat casualties evacuated from the Middle East shows that nearly one-third of 33 wounded troops were carrying bacteria resistant to multiple antibiotics. This alarming trend highlights a potential crisis for military medical systems, especially in large-scale conflicts where infections could severely impact combat readiness. The issue is not new, but experts warn it is worsening as bacteria evolve faster than new antibiotics are developed. The threat has reached Congress, but current defense bill proposals lack mandatory action, focusing instead on encouraging research and investment in infection prevention.

Antibiotic resistance poses a serious challenge to battlefield care

Major General Clinton Murray, the Joint Staff surgeon and an infectious disease physician, emphasized that the presence of drug-resistant bacteria is not a new phenomenon but one that is becoming increasingly critical. While only one of the 33 evacuated troops developed an active infection, the fact that many were “colonized” with resistant bacteria underscores the potential for widespread complications. Murray noted that these findings are consistent with global rates and do not indicate an outbreak, but they serve as an early warning sign. “It’s not going to go away. It’s only going to get worse.”

Early detection is key to preventing infection spread

Colonel Jennifer Gurney, director of the Joint Trauma System, stressed the importance of early detection in battlefield care. “Smell should not be our best early diagnostic capability,” she said, criticizing the reliance on clinical intuition rather than advanced diagnostics. Gurney highlighted that current medical tools for identifying infections have not kept pace with other areas of medicine, leaving the military vulnerable in large-scale conflicts. “Our current approach is probably not working as well as we want it to.” She compared the threat of multidrug-resistant organisms to the rise of inexpensive drones, both of which can overwhelm traditional defenses.

Experts argue that the military must rethink its strategy for managing infections, moving away from reliance on antibiotics and toward more innovative solutions. “We must change the timeline and move capabilities and diagnostics much closer to the point of need,” Gurney said. “If we’ve been doing the same thing for 100 years and it hasn’t been working, we really have to think about the strategy,” she added. The challenge is not just medical but strategic, as infections could become a “second hit” to combat power, reducing the effectiveness of troops on the battlefield.

Such a devastating war could leave thousands of severely wounded troops waiting days or weeks for evacuation, receiving prolonged care on the battlefield, where wounds may become contaminated with soil, debris, and bacteria. Those who survive are likely to process through crowded hospitals, where pathogens can spread and infections can proliferate. The resulting conditions could resemble the frequently overwhelmed casualty flows of World War I and World War II. “Infection is a second hit and a threat to combat power,” Gurney said, underscoring the gravity of the situation. The battle against antibiotic resistance is not just a medical issue—it is a strategic one.